Type 1 Diabetes Clinical Trials in New Haven, Connecticut

5 studies are recruiting for type 1 diabetes in New Haven, Connecticut right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

   This multi-center randomized controlled trial will assess the safety and efficacy of ATG followed by either adalimumab or verapamil in preserving insulin secretion 2 years from randomization in persons aged 9 to <21 with recent-onset stage 3 T1D.

   Stage

   Phase 1

   Ages

   9 to 20

   Site

   Yale University, New Haven, Connecticut

   Locations

   10 in total

   Run by

   City of Hope Medical Center

   See if you can join NCT07061574 on ClinicalTrials.gov

2. Registry for Stage 2 Type 1 Diabetes

   Stage 2 Type 1 Diabates (T1D) is an early stage of T1D characterized by dysglycemia but not yet leading to clinical symptoms. Progression of the disease to Stage 3 (clinical T1D), leads to overt hyperglycemia requiring eventually exogenous insulin. TZIELD® (teplizumab-mzwv) has been approved to del…

   Stage

   Not phased

   Ages

   Any age

   Site

   Yale University School of Medicine- Site Number : 8400025, New Haven, Connecticut

   Locations

   37 in total

   Run by

   Sanofi

   See if you can join NCT06481904 on ClinicalTrials.gov

3. Home-based Oral Glucose Tolerance Test for Type 1 Diabetes Screening

   This study aims at quantifying the accuracy of a self-administered fingerstick based glucose tolerance test (GTT@Home) respect to the gold-standard in-clinic venous plasma measures during the oral glucose tolerance test (OGTT) across a wide range of glycemic values in people at risk for clinical ty…

   Stage

   Not phased

   Ages

   8 to 45

   Site

   Yale University Pediatric and Adult Diabetes Clinic, New Haven, Connecticut

   Run by

   Yale University

   See if you can join NCT07155252 on ClinicalTrials.gov

4. T1CARE: A Trial of a Novel Intervention to Address Social Determinants of Health in Young Adults With Type 1 Diabetes

   Randomized controlled trial with a wait list control arm. Participants will be randomized 1:1 to T1CARE or wait list usual care arm. Participants will be recruited from the Yale Adult and Pediatric Diabetes Centers. Patients assigned to T1CARE will receive support from a Community Health Navigator …

   Stage

   Not phased

   Ages

   18 to 40

   Site

   Yale Adult Diabetes Center, New Haven, Connecticut

   Locations

   2 in total

   Run by

   Yale University

   See if you can join NCT07059806 on ClinicalTrials.gov

5. Glu-COACH: a Peer-mentoring Intervention to Reduce Disparities in Continuous Glucose Monitor (CGM) Use

   This is a study to develop and evaluate a peer mentoring intervention for Black and Latinx adolescents with type 1 diabetes to increase the initiation and maintenance of a continuous glucose monitoring (CGM) device. This device is a standard of care to improve diabetes management related to diet, e…

   Stage

   Not phased

   Ages

   13 to 21

   Site

   Yale Children's Diabetes Clinic, New Haven, Connecticut

   Run by

   Yale University

   See if you can join NCT06171412 on ClinicalTrials.gov